Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease.

2020 
Background: Primary non-response to infliximab (IFX) inherits a poor prognosis in inflammatory bowel disease (IBD). We explored underlying mechanisms and therapeutic thresholds in an effort to prov...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    30
    References
    5
    Citations
    NaN
    KQI
    []